Point of Care Immunoassay Diagnostic Platform

在诊断速度至关重要的紧急医疗情况下，有效的近患者或Pointof-Care（PoC）检测可以发挥至关重要的作用。在需要持续监测的紧急情况或重症监护环境中进行快速检测的能力将大大加快患者的分类、诊断、治疗和处置。快速检测可以有效地减少不必要的住院和中心实验室的负担。然而，许多可用的生物传感器技术缺乏提供完全定量测量所需的灵敏度和准确度;这是未来生物传感器设备的医疗保健专业人员现在所要求的先决条件。Bio-Alternative Medical Devices（Bio-AMD）已经发现了市场上的这一差距，并设计了一个可扩展的平台，该平台将提供更准确测量所需的灵敏度水平，并具有黄金标准实验室的精度。

In acute medical situations, where speed of diagnosis is critical, effective near-patient or Pointof-Care (PoC) testing can play a crucial role. The ability to conduct a rapid test in an emergency or critical care setting, where continuous monitoring is required, will significantly accelerate the triage, diagnosis, treatment and disposition of patients. PoC testing can effectively reduce unnecessary hospital admissions and the burden placed on centralisedlaboratories. However, many of the PoC technologies available lack the required sensitivity and accuracy to provide fully quantitative measurements; a pre-requisite now demanded by healthcare professionals of future PoC devices. Bio-Alternative Medical Devices (Bio-AMD) has identified this gap in the market and has devised a PoC platform that will deliver the levelof sensitivity required for significantly more accurate measurements with the precision of gold standard laboratories.